Kidney Disease Clinical Trials in San Antonio

Showing 201-220 of 340 trials

Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors

NCT02897778

The purpose of this study is to evaluate the effect of entinostat on heart rate and other electrocardiogram (ECG) parameters. This study will also evaluate the safety and tolerability of entinostat, as well as pharmacokinetic and pharmacodynamic parameters.

NeoplasmsNeoplasms, Glandular and EpithelialNeoplasms by Histologic Type+12 more

Syndax Pharmaceuticals30 participantsStarted Aug 2016

San Antonio, Texas, United States

COMPLETEDPhase 4< 1 mile

Compare Efficacy/Safety of Repeat Doses of Ferumoxytol With Iron Sucrose in CKD Subjects With IDA and on Hemodialysis

NCT01227616

The objectives of this study are to compare the efficacy and safety of repeat doses of intravenous (IV) ferumoxytol with IV iron sucrose for the treatment of IDA in subjects with hemodialysis-dependent CKD.

Iron Deficiency Anemia TreatmentChronic Kidney Disease(CKD)

AMAG Pharmaceuticals, Inc.296 participantsStarted Aug 2013

Pine Bluff, Arkansas, United States • Azusa, California, United States • Beverly Hills, California, United States +40 more locations

Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors

Compare Efficacy/Safety of Repeat Doses of Ferumoxytol With Iron Sucrose in CKD Subjects With IDA and on Hemodialysis

Kidney Disease Trials in Other Cities

Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease

TARGTEPO Treatment for Anemia in PD US Trial

Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery

Study of Roxadustat (FG-4592) in Participants With End-Stage Renal Disease Receiving Maintenance Hemodialysis

Study to Evaluate the Efficacy and Safety of Roxadustat in the Treatment of Anemia in Participants With ESRD on Stable Dialysis

A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients

A Study to Evaluate the Effect of Renal Impairment on JNJ-56136379 in Adult Participants

Safety Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Renal Failure

Nivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC) (CheckMate 016)

A Cross-Sectional Study to Assess Walking Performance in Subjects With Peripheral Artery and End Stage Kidney Disease

Tolvaptan Extension Study in Participants With ADPKD

Open-Label Extension Study for the Long-Term Efficacy and Safety of Roxadustat in Participants With Dialysis and Non-Dialysis Chronic Kidney Disease

Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers

Phase 1/1b Study to Evaluate the Safety and Tolerability of Ciforadenant Alone and in Combination With Atezolizumab in Advanced Cancers

Safety Study of MGA271 in Refractory Cancer

Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies.

A Phase 1 Study of Nivolumab (BMS-936558) in Subjects With Advanced or Recurrent Malignancies

Phase I Biomarker Study (BMS-936558)

Other Conditions in San Antonio